All Stories

  1. NSP1 of human rotaviruses commonly inhibits NF-κB signalling by inducing β-TrCP degradation
  2. Revisiting the role of histo-blood group antigens in rotavirus host-cell invasion
  3. VP7 of Rhesus monkey rotavirus RRV contributes to diabetes acceleration in association with an elevated anti-rotavirus antibody response
  4. Rotavirus inhibits IFN-induced STAT nuclear translocation by a mechanism that acts after STAT binding to importin- 
  5. Rotavirus Activates Lymphocytes from Non-Obese Diabetic Mice by Triggering Toll-Like Receptor 7 Signaling and Interferon Production in Plasmacytoid Dendritic Cells
  6. Relative Roles of GM1 Ganglioside, N-Acylneuraminic Acids, and  2 1 Integrin in Mediating Rotavirus Infection
  7. Rotavirus acceleration of murine type 1 diabetes is associated with increased MHC class I-restricted antigen presentation by B cells and elevated proinflammatory cytokine expression by T cells
  8. Alteration of the Thymic T Cell Repertoire by Rotavirus Infection Is Associated with Delayed Type 1 Diabetes Development in Non-Obese Diabetic Mice
  9. Innate cellular responses to rotavirus infection
  10. Rotavirus acceleration of murine type 1 diabetes is associated with a T helper 1-dependent specific serum antibody response and virus effects in regional lymph nodes
  11. Structural Basis of Rotavirus Strain Preference toward N-Acetyl- or N-Glycolylneuraminic Acid-Containing Receptors
  12. Novel Structural Insights into Rotavirus Recognition of Ganglioside Glycan Receptors
  13. Cross-Linking of Rotavirus Outer Capsid Protein VP7 by Antibodies or Disulfides Inhibits Viral Entry
  14. Rücktitelbild: Rhesus-Rotaviren erkennen Glykane des GM3-Gangliosids (Angew. Chem. 5/2011)
  15. Back Cover: Recognition of the GM3 Ganglioside Glycan by Rhesus Rotavirus Particles (Angew. Chem. Int. Ed. 5/2011)
  16. Rhesus-Rotaviren erkennen Glykane des GM3-Gangliosids
  17. Recognition of the GM3 Ganglioside Glycan by Rhesus Rotavirus Particles
  18. Determinants of the Specificity of Rotavirus Interactions with the  2 1 Integrin
  19. The Type III Effectors NleE and NleB from Enteropathogenic E. coli and OspZ from Shigella Block Nuclear Translocation of NF-κB p65
  20. Death mechanisms in epithelial cells following rotavirus infection, exposure to inactivated rotavirus or genome transfection
  21. Rotavirus Antagonizes Cellular Antiviral Responses by Inhibiting the Nuclear Accumulation of STAT1, STAT2, and NF-κB
  22. Sialic acid dependence in rotavirus host cell invasion
  23. Effects on sialic acid recognition of amino acid mutations in the carbohydrate-binding cleft of the rotavirus spike protein
  24. Crystallization and preliminary X-ray diffraction analysis of the carbohydrate-recognizing domain (VP8*) of bovine rotavirus strain NCDV
  25. Rotavirus Infection Accelerates Type 1 Diabetes in Mice with Established Insulitis
  26. Rotavirus Replication in Intestinal Cells Differentially Regulates Integrin Expression by a Phosphatidylinositol 3-Kinase-Dependent Pathway, Resulting in Increased Cell Adhesion and Virus Yield
  27. Rotavirus Infection of Infant and Young Adult Nonobese Diabetic Mice Involves Extraintestinal Spread and Delays Diabetes Onset
  28. Insight into Host Cell Carbohydrate-recognition by Human and Porcine Rotavirus from Crystal Structures of the Virion Spike Associated Carbohydrate-binding Domain (VP8*)
  29. Rotavirus-neutralizing antibodies inhibit virus binding to integrins α2β1 and α4β1
  30. STD NMR spectroscopy and molecular modeling investigation of the binding of N-acetylneuraminic acid derivatives to rhesus rotavirus VP8* core
  31. Rotavirus Activates JNK and p38 Signaling Pathways in Intestinal Cells, Leading to AP-1-Driven Transcriptional Responses and Enhanced Virus Replication
  32. The synthesis and biological evaluation of lactose-based sialylmimetics as inhibitors of rotaviral infection
  33. Cloning, expression, purification, crystallization and preliminary X-ray diffraction analysis of the VP8* carbohydrate-binding protein of the human rotavirus strain Wa
  34. Evaluation of specificity and effects of monoclonal antibodies submitted to the Eighth Human Leucocyte Differentiation Antigen Workshop on rotavirus-cell attachment and entry
  35. Crystallization and preliminary X-ray diffraction analysis of the sialic acid-binding domain (VP8*) of porcine rotavirus strain CRW-8
  36. Effects on Rotavirus Cell Binding and Infection of Monomeric and Polymeric Peptides Containing α2β1 and αxβ2 Integrin Ligand Sequences
  37. Incidence of Group C Human Rotavirus in Central Australia and Sequence Variation of the VP7 and VP4 Genes
  38. Integrin-Using Rotaviruses Bind α2β1 Integrin α2 I Domain via VP4 DGE Sequence and Recognize αXβ2 and αVβ3 by Using VP7 during Cell Entry
  39. Monkey Rotavirus Binding to α2β1 Integrin Requires the α2 I Domain and Is Facilitated by the Homologous β1 Subunit
  40. Growth of Rotaviruses in Primary Pancreatic Cells
  41. Phorbol dibutyrate-induced megakaryocytic differentiation increases susceptibility of K562 cells to SA11 rotavirus infection
  42. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes
  43. Integrins α2β1 and α4β1 Can Mediate SA11 Rotavirus Attachment and Entry into Cells
  44. Rotavirus contains integrin ligand sequences and a disintegrin-like domain that are implicated in virus entry into cells
  45. G3P2 rotaviruses causing diarrhoeal disease in neonates differ in VP4, VP7 and NSP4 sequence from G3P2 strains causing asymptomatic neonatal infection
  46. Multiple-gene rotavirus reassortants responsible for an outbreak of gastroenteritis in central and northern Australia
  47. Human rotavirus VP4 contains strain-specific, serotype-specific and cross-reactive neutralization sites
  48. Amino acids involved in distinguishing between monotypes of rotavirus G serotypes 2 and 4
  49. Rotavirus Antigenicity Is Affected by the Genetic Context and Glycosylation of VP7
  50. Characteristics and Location of Cross-Reactive and Serotype-Specific Neutralization Sites on VP7 of Human G Type 9 Rotaviruses
  51. Evaluation of end-point titration, single dilution and capture enzyme immunoassays for measurement of antirotaviral IgA and IgM in infantile secretions and serum
  52. Non-neutralizing monoclonal antibodies to a trypsin-sensitive site on the major glycoprotein of rotavirus which discriminate between virus serotypes
  53. Variation in neutralization epitopes of human rotaviruses in relation to genomic RNA polymorphism
  54. Antigenic mapping of the surface proteins of rhesus rotavirus
  55. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3
  56. An improved enzyme-linked immunosorbent assay for the detection of rotavirus in faeces of neonates